CoreAge Rx vs QuickMD
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and QuickMD head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 60 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make QuickMD a bad call — it's best for people seeking a pay-per-visit clinician consultation who understand that the pharmacy charge and prescription decision are separate. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | QuickMD |
|---|---|---|
| Brief Score | 94/100 (A) | 60/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | $99 consultation + medication extra No membership required. Branded and compounded choices advertised; complete selected medication price and supply unconfirmed. Completed visit nonrefundable even if requested drug declined. Cancel at least one hour ahead to avoid a $35 visit-credit deduction; pharmacy refunds are separate. Full price detailsBranded and compounded semaglutide choices advertised; complete medication quote unknown; weight-care consultation $99 per visit, medication paid separately at the chosen pharmacy |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | $99 consultation + medication extra No membership required. Branded and compounded choices advertised; complete selected medication price and supply unconfirmed. Completed visit nonrefundable even if requested drug declined. Cancel at least one hour ahead to avoid a $35 visit-credit deduction; pharmacy refunds are separate. Full price detailsBranded and compounded tirzepatide choices advertised; complete medication quote unknown; weight-care consultation $99 per visit, medication paid separately at the chosen pharmacy |
| Coverage | US only; restrictions by state, confirmed at intake | Weight-care page explicitly says “Not available in LA”; other eligibility depends on clinician licensing and the patient’s location. Confirm weight-care access before paying. |
| Brand-name access | Not confirmed | Yes |
| Oral / sublingual | Injection only | Yes |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
QuickMD: Weight-care visit $99, medication extra. Completed visits are nonrefundable; cancel at least one hour ahead to avoid a $35 credit deduction. Exact pharmacy quote depends on product and coverage.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.